跳至主要内容
临床试验/ITMCTR2100004326
ITMCTR2100004326招募中1 期

Clinical study on the multi-center randomized controlled optimization scheme of Shugan Tiaoshen integrated acupuncture in the treatment of moderate depressive disorder

Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. In line with the diagnostic criteria of Chinese and Western medicine;
  • 2. Age 18 ~ 65 years old, junior high school (including) or above;
  • 3. The 17 Hamilton Depression Scale (HAMD-17) scores were > 17 and <= 24;
  • 4. Signed the informed consent and volunteered to participate in the study.
  • Only those who meet the above four criteria can be included in the study.

排除标准

  • 1. People with suicidal tendencies;
  • 2. Previous diagnosis of mental disorders, schizophrenia, bipolar disorder, substance abuse (such as: alcohol dependence) or other mental disorders;
  • 3. Epileptic seizure history or strong positive family history of epilepsy, brain organic disease and severe physical disease;
  • 4. Taking antidepressant drugs within 6 weeks (including 6 weeks);
  • 5. Pregnancy, pregnancy preparation or lactation;
  • 6. Patients with skin lesions or skin diseases, severe diabetes mellitus, tumors, insufficiency of important organs or serious internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory system and hematopoietic system;
  • Those who meet any of the above criteria will be excluded from the study.

研究者

发起方
Guangdong Provincial Hospital of Traditional Chinese Medicine

相似试验

Clinical study on the multi-center randomized... | 临床试验